Mechanically, evidence also showed that NFKB1 was a negative regulator of the NF-κB, which could upregulate expression of anti-apoptotic genes, such as IAPs, cell-cycle promoters, and growth factors and their receptors [28], further supporting its tumour suppressive role. The gene discussed is NFKB1; the disease is neoplasm.